• Issue
    2017
    165-276
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION
Free Access

Issue Information

  • Pages: 165-167
  • First Published: 02 August 2017

REVIEW ARTICLE

Safety concerns and risk management of multiple sclerosis therapies

P. Soelberg Sorensen, 
  • Pages: 168-186
  • First Published: 27 November 2016

ORIGINAL ARTICLE

Cognitive function in stroke survivors: A 10-year follow-up study

H. Delavaran,  A.-C. Jönsson,  H. Lövkvist,  S. Iwarsson,  S. Elmståhl,  B. Norrving,  A. Lindgren, 
  • Pages: 187-194
  • First Published: 01 November 2016
ORIGINAL ARTICLE

The value of the bulbocavernosus reflex and pudendal nerve somatosensory evoked potentials in distinguishing between multiple system atrophy and Parkinson's disease at an early stage

Z.-Y. Cai,  X.-T. Niu,  J. Pan,  P.-Q. Ni,  X. Wang,  B. Shao, 
  • Pages: 195-203
  • First Published: 10 November 2016
ORIGINAL ARTICLE

The concept and diagnostic criteria of primary lateral sclerosis

Verena Wais,  Angela Rosenbohm,  Susanne Petri,  Katja Kollewe,  Andreas Hermann,  Alexander Storch,  Frank Hanisch,  Stephan Zierz,  Gabriele Nagel,  Jan Kassubek,  Patrick Weydt,  Johannes Brettschneider,  Jochen H. Weishaupt,  Albert C. Ludolph,  Johannes Dorst, 
  • Pages: 204-211
  • First Published: 15 November 2016
ORIGINAL ARTICLE

Cerebrospinal fluid cytotoxicity does not affect survival in amyotrophic lateral sclerosis

L. Galán,  J. Matías-Guiu,  J. A. Matias-Guiu,  M. Yáñez,  V. Pytel,  A. Guerrero-Sola,  A. Vela-Souto,  J. A. Arranz-Tagarro,  U. Gómez-Pinedo,  A. G. García, 
  • Pages: 212-216
  • First Published: 29 December 2016
ORIGINAL ARTICLE

A longitudinal real-life comparison study of natalizumab and fingolimod

R. Lanzillo,  A. Carotenuto,  M. Moccia,  F. Saccà,  C. V. Russo,  M. Massarelli,  A. De Rosa,  V. Brescia Morra, 
  • Pages: 217-222
  • First Published: 15 December 2016
ORIGINAL ARTICLE

Multiple Sclerosis impact on employment and income in New Zealand

J. F. Pearson,  S. Alla,  G. Clarke,  D. F. Mason,  T. Anderson,  A. Richardson,  D. H. Miller,  C. E. Sabel,  D. A. Abernethy,  E. W. Willoughby,  B. V. Taylor, 
  • Pages: 223-232
  • First Published: 28 November 2016
ORIGINAL ARTICLE

Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis

R. Tanasescu,  A. Midgley,  R. A. Robins,  C. S. Constantinescu, 
  • Pages: 233-238
  • First Published: 05 December 2016
ORIGINAL ARTICLE

Prognostic parameters and outcome after re-irradiation for progressive glioblastoma

K. Zwirner,  F. Paulsen,  J. Schittenhelm,  C. Borchers,  M. Skardelly,  D. Zips,  F. Eckert, 
  • Pages: 239-245
  • First Published: 26 December 2016
ORIGINAL ARTICLE

Epilepsy and adverse quality of life in surgically resected meningioma

M. J. Tanti,  A. G. Marson,  M. D. Jenkinson, 
  • Pages: 246-253
  • First Published: 14 November 2016
ORIGINAL ARTICLE

EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

V. Villanueva,  P. Bermejo,  J. Montoya,  M. Toledo,  A. Gómez-Ibáñez,  M. Garcés,  L. Vilella,  F. J. López-González,  X. Rodriguez-Osorio,  D. Campos,  P. Martínez,  P. Giner,  J. Zurita,  J. Rodríguez-Uranga,  J. Ojeda,  J. A. Mauri,  J. L. Camacho,  J. Ruiz-Giménez,  J. J. Poza,  A. Massot-Tarrús,  M. L. Galiano,  M. Bonet, 
  • Pages: 254-264
  • First Published: 09 December 2016
ORIGINAL ARTICLE

Identifying patients at risk of acute symptomatic seizure after ischemic stroke

K. N. Alme,  B. A. Engelsen,  M. Naik,  H. Næss, 
  • Pages: 265-271
  • First Published: 26 December 2016
ORIGINAL ARTICLE

Extended EEG and non-convulsive status epilepticus: Benefit over routine EEG?

E. Eskioglou,  C. Stähli,  A. O. Rossetti,  J. Novy, 
  • Pages: 272-276
  • First Published: 27 December 2016